Johnson & Johnson said on Friday it discontinued a mid-stage study of its experimental drug to treat patients with moderate ...

Gilead Sciences said on Monday its experimental HIV treatment was found to be statistically non-inferior to its top-selling drug Biktarvy in a late-stage trial. The experimental regimen could expand ...

Throughout Destiny 2's life cycle, Bungie has never been able to capture the same magic it did with the original iteration of Destiny's Trials of Osiris. Of course, it is an uphill battle for the ...

Good news for people on GLP-1 therapy who hate needles: Trial data out this week shows that an experimental pill developed by Eli Lilly could offer an intriguing off-ramp.

To be accepted into a clinical trial, all potential participants must meet the "eligibility criteria" by having similar ...

Some sharks get a new set of teeth every few weeks, while crocodiles can go through thousands of chompers in their long lifetimes. Yet the ability to endlessly replace our pearly whites is something ...